Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.64 |
| ▸ | CA9 | Q16790 | 2/20 | 0.64 |
| ▸ | MAOB | P27338 | 3/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.44 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.44 |
| ▸ | ALPL | P05186 | 1/20 | 0.44 |
| ▸ | ALPI | P09923 | 1/20 | 0.44 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.43 |
| ▸ | CCNK | O75909 | 1/20 | 0.43 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | CDK9 | P50750 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2996087 | 0.89 | CA12 (0.53) | CA12CA9MAOBMAOAMAPT | |
| SCHEMBL6578120 | 0.89 | CA12 (0.53) | CA12CA9MAOBMAOAMAPT | |
| SCHEMBL125671 | 0.80 | HSD17B3 (0.71) | CA12CA9MAOBMAPTKMT2A | |
| SCHEMBL7944663 | 0.78 | SRC (0.53) | CA12CA9MAPTHSD17B3CCNT1 | |
| SCHEMBL9277041 | 0.75 | CA12 (0.60) | CA12CA9MAOBMAOAMAPT | |
| SCHEMBL6578121 | 0.75 | CA12 (0.50) | CA12CA9MAOBMAOAMAPT | |
| SCHEMBL5332842 | 0.74 | MAPT (0.63) | CA12CA9MAOBMAOAMAPT | |
| SCHEMBL2369946 | 0.73 | HTT (0.51) | CA12CA9MAPTKMT2AMEN1 | |
| SCHEMBL26987736 | 0.73 | CA12 (0.80) | CA12CA9MAOBMAOAMAPT | |
| SCHEMBL7795084 | 0.73 | GPR35 (0.54) | CA12CA9MAPTKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1124986-B1 | NITROCOUMARINS FOR DETECTING ALL MICRO-ORGANISMS | BIOMERIEUX SA (FR) | 2004-05-06 | — | — | EP | disclosed |
| US-6555332-B2 | Calibration using fluorescence signals | BIOMERIEUX S.A. (FR) | 2003-04-29 | — | — | US | disclosed |
| US-20020031795-A1 | Nitrocoumarins for detecting all micro-organisms | BIOMERIEUX S.A. (FR) | 2002-03-14 | — | — | US | disclosed |
| EP-1124986-A1 | NITROCOUMARINS FOR DETECTING ALL MICRO-ORGANISMS | Biomerieux S.A. (FR) | 2001-08-22 | — | — | EP | disclosed |
| WO-2000028073-A1 | NITROCOUMARINS FOR DETECTING ALL MICRO-ORGANISMS | BIOMERIEUX S.A. (FR) | 2000-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020031795-A1 | Nitrocoumarins for detecting all micro-organisms | CBR3, CYB5R3, CBR1 | CA12 4339/4885CA9 3105/4885MAOB 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.